News Roundup March 6-March 10


Your weekly roundup of the latest news from Drug Topics®.

Racial, Ethnic Inequities Persist in Diabetes Care

Significant differences in the use of insulin pump and/or CGM technology were noted based on demographic and socioeconomic factors

Read More

FDA Clears First Commercially Available Blood Test to Evaluate for TBI, Concussion

The test is intended to complement the company’s TBI plasma test, which received FDA clearance in 2021.

Read More

FDA Sets Target Date To Expand Dwarfism Care Voxzogo To Younger Children

Voxzogo is already available for patients over 5 years with a genetic cause of dwarfism. The PDUFA date is set for Oct. 21, 2023, and will potentially expand the drug to children 5 and under.

Read More

FDA Accepts Biologics License Application for Proposed Denosumab Biosimilar

The drug, manufactured by Sandoz, will treat conditions including osteoporosis in postmenopausal women

Read More

Show Them The Money

The role of the pharmacy technician has evolved over the past 45 years—but pay hasn’t caught up

Read More

Related Videos
© 2024 MJH Life Sciences

All rights reserved.